Independent Advisor Alliance’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$732K Sell
2,038
-213
-9% -$65.1K 0.02% 550
2026
Q1
$564K Buy
2,251
+28
+1% +$6.97K 0.01% 1064
2025
Q4
$612K Sell
2,223
-280
-11% -$76.6K 0.01% 590
2025
Q3
$657K Buy
2,503
+10
+0.4% +$2.43K 0.02% 546
2025
Q2
$545K Buy
2,493
+96
+4% +$20.5K 0.02% 562
2025
Q1
$537K Sell
2,397
-281
-10% -$77.4K 0.02% 507
2024
Q4
$877K Buy
2,678
+597
+29% +$188K 0.01% 760
2024
Q3
$625K Buy
2,081
+389
+23% +$119K 0.02% 413
2024
Q2
$557K Buy
1,692
+83
+5% +$29.3K 0.02% 437
2024
Q1
$637K Buy
1,609
+364
+29% +$135K 0.02% 407
2023
Q4
$438K Sell
1,245
-882
-41% -$312K 0.02% 463
2023
Q3
$798K Buy
2,127
+58
+3% +$22.4K 0.04% 326
2023
Q2
$791K Sell
2,069
-355
-15% -$127K 0.03% 337
2023
Q1
$840K Buy
+2,424
New +$708K 0.04% 312
2022
Q4
– Sell
-1,806
Closed -$444K – 633
2022
Q3
$444K Buy
1,806
+715
+66% +$218K 0.03% 400
2022
Q2
$330K Buy
1,091
+93
+9% +$30.3K 0.02% 465
2022
Q1
$410K Buy
998
+344
+53% +$135K 0.02% 441
2021
Q4
$307K Buy
+654
New +$282K 0.02% 517

Other funds holding WST

Independent Advisor Alliance's WST Position: Q2 2026 in Review

Independent Advisor Alliance reduced its West Pharmaceutical (WST) stake by 9.5% in Q2 2026, selling an estimated $65.1K and leaving 2,038 shares worth $732K. The position accounts for 0.02% of the portfolio, ranked #550.

Independent Advisor Alliance first reported a position in WST in Q4 2021 and has held it in 18 quarters since. The position peaked at $877K in Q4 2024. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Independent Advisor Alliance held 2,038 shares of West Pharmaceutical worth $732K as of Q2 2026.
  • Independent Advisor Alliance sold 213 West Pharmaceutical shares in Q2 2026, an estimated $65.1K.
  • West Pharmaceutical made up 0.02% of Independent Advisor Alliance's portfolio in Q2 2026, its #550 holding.
  • Independent Advisor Alliance first reported a position in West Pharmaceutical in Q4 2021 and has held it in 18 quarters since.
  • Independent Advisor Alliance's West Pharmaceutical position peaked at $877K in Q4 2024.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Independent Advisor Alliance's 13F filing for Q2 2026, filed 12 Aug 2026.